語系:
繁體中文
English
說明(常見問題)
回圖書館首頁
手機版館藏查詢
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Cancer stem cell resistance to targe...
~
Maccalli, Cristina.
FindBook
Google Book
Amazon
博客來
Cancer stem cell resistance to targeted therapy
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
Cancer stem cell resistance to targeted therapy/ edited by Cristina Maccalli, Matilde Todaro, Soldano Ferrone.
其他作者:
Maccalli, Cristina.
出版者:
Cham :Springer International Publishing : : 2019.,
面頁冊數:
xix, 256 p. :ill., digital ;24 cm.
內容註:
Cancer Stem Cells: from birth to death -- A Cancer Stem Cell Perspective on Minimal Residual Disease in Solid Malignancies -- Cancer Stem Cells in Lung Cancer: Roots of Drug Resistance and Targets for Novel Therapeutic Strategies -- Overexpression of YY1 Regulates the Resistance of Cancer Stem Cells: Targeting YY1 -- Cancer Stem Cell Challenges in Melanoma Characterization and Treatment -- Harnessing the immune system to target cancer cells -- Targeting leukemia stem cells and the immunological bone marrow microenvironment -- Crosstalk Between Prostate Cancer Stem Cells and Immune Cells: Implications for Tumor Progression and Resistance to Immunotherapy -- Cancer stem cells: the players of immune evasion from immunotherapy -- Index.
Contained By:
Springer eBooks
標題:
Drug resistance in cancer cells. -
電子資源:
https://doi.org/10.1007/978-3-030-16624-3
ISBN:
9783030166243
Cancer stem cell resistance to targeted therapy
Cancer stem cell resistance to targeted therapy
[electronic resource] /edited by Cristina Maccalli, Matilde Todaro, Soldano Ferrone. - Cham :Springer International Publishing :2019. - xix, 256 p. :ill., digital ;24 cm. - Resistance to targeted anti-cancer therapeutics,v.192196-5501 ;. - Resistance to targeted anti-cancer therapeutics ;v.19..
Cancer Stem Cells: from birth to death -- A Cancer Stem Cell Perspective on Minimal Residual Disease in Solid Malignancies -- Cancer Stem Cells in Lung Cancer: Roots of Drug Resistance and Targets for Novel Therapeutic Strategies -- Overexpression of YY1 Regulates the Resistance of Cancer Stem Cells: Targeting YY1 -- Cancer Stem Cell Challenges in Melanoma Characterization and Treatment -- Harnessing the immune system to target cancer cells -- Targeting leukemia stem cells and the immunological bone marrow microenvironment -- Crosstalk Between Prostate Cancer Stem Cells and Immune Cells: Implications for Tumor Progression and Resistance to Immunotherapy -- Cancer stem cells: the players of immune evasion from immunotherapy -- Index.
This book represents an updated summary of the state of the art of the characterization of cancer stem cell/cancer initiating cell (CSC/CIC) properties. Experts provide an overview of the definition and biological properties of CSCs/CICs as well as the role of these cells in determining the resistance to standard and immune-based therapies. It also discusses limitations in the achievement of a definitive biological characterization of CSCs/CICs due to their high extent of plasticity and heterogeneity that is also mutually driven by the interaction of these cells with the tumor microenvironment. The limitations in targeting CSCs/CICs with immunotherapy are also explained together with explorative combination approaches that could increase the susceptibility of these cells to the recognition by immune cells. This book is conceived for a broad audience, including students, teachers, scientific experts. The critical revision of available results in terms of immunological profile of CSCs/CICs and the efficacy in targeting these cells by immunological approaches, results in a comprehensive and up to date recapitulation of the field and provides interesting suggestions on how to focus future investigations in order to assess the role of CSCs/CICs as prognostic and predictive biomarkers of responsiveness to therapies for cancer patients.
ISBN: 9783030166243
Standard No.: 10.1007/978-3-030-16624-3doiSubjects--Topical Terms:
658434
Drug resistance in cancer cells.
LC Class. No.: RC271.C5 / C36 2019
Dewey Class. No.: 614.5999
Cancer stem cell resistance to targeted therapy
LDR
:03190nmm a2200337 a 4500
001
2191914
003
DE-He213
005
20190604100716.0
006
m d
007
cr nn 008maaau
008
200506s2019 gw s 0 eng d
020
$a
9783030166243
$q
(electronic bk.)
020
$a
9783030166236
$q
(paper)
024
7
$a
10.1007/978-3-030-16624-3
$2
doi
035
$a
978-3-030-16624-3
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC271.C5
$b
C36 2019
072
7
$a
MJCL
$2
bicssc
072
7
$a
MED062000
$2
bisacsh
072
7
$a
MJCL
$2
thema
082
0 4
$a
614.5999
$2
23
090
$a
RC271.C5
$b
C215 2019
245
0 0
$a
Cancer stem cell resistance to targeted therapy
$h
[electronic resource] /
$c
edited by Cristina Maccalli, Matilde Todaro, Soldano Ferrone.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2019.
300
$a
xix, 256 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Resistance to targeted anti-cancer therapeutics,
$x
2196-5501 ;
$v
v.19
505
0
$a
Cancer Stem Cells: from birth to death -- A Cancer Stem Cell Perspective on Minimal Residual Disease in Solid Malignancies -- Cancer Stem Cells in Lung Cancer: Roots of Drug Resistance and Targets for Novel Therapeutic Strategies -- Overexpression of YY1 Regulates the Resistance of Cancer Stem Cells: Targeting YY1 -- Cancer Stem Cell Challenges in Melanoma Characterization and Treatment -- Harnessing the immune system to target cancer cells -- Targeting leukemia stem cells and the immunological bone marrow microenvironment -- Crosstalk Between Prostate Cancer Stem Cells and Immune Cells: Implications for Tumor Progression and Resistance to Immunotherapy -- Cancer stem cells: the players of immune evasion from immunotherapy -- Index.
520
$a
This book represents an updated summary of the state of the art of the characterization of cancer stem cell/cancer initiating cell (CSC/CIC) properties. Experts provide an overview of the definition and biological properties of CSCs/CICs as well as the role of these cells in determining the resistance to standard and immune-based therapies. It also discusses limitations in the achievement of a definitive biological characterization of CSCs/CICs due to their high extent of plasticity and heterogeneity that is also mutually driven by the interaction of these cells with the tumor microenvironment. The limitations in targeting CSCs/CICs with immunotherapy are also explained together with explorative combination approaches that could increase the susceptibility of these cells to the recognition by immune cells. This book is conceived for a broad audience, including students, teachers, scientific experts. The critical revision of available results in terms of immunological profile of CSCs/CICs and the efficacy in targeting these cells by immunological approaches, results in a comprehensive and up to date recapitulation of the field and provides interesting suggestions on how to focus future investigations in order to assess the role of CSCs/CICs as prognostic and predictive biomarkers of responsiveness to therapies for cancer patients.
650
0
$a
Drug resistance in cancer cells.
$3
658434
650
0
$a
Oncology.
$3
751006
650
0
$a
Immunology.
$3
611031
650
0
$a
Medicine.
$3
641104
650
1 4
$a
Cancer Research.
$3
891172
650
2 4
$a
Molecular Medicine.
$3
890952
700
1
$a
Maccalli, Cristina.
$3
3411720
700
1
$a
Todaro, Matilde.
$3
3411721
700
1
$a
Ferrone, Soldano.
$3
3411722
710
2
$a
SpringerLink (Online service)
$3
836513
773
0
$t
Springer eBooks
830
0
$a
Resistance to targeted anti-cancer therapeutics ;
$v
v.19.
$3
3411723
856
4 0
$u
https://doi.org/10.1007/978-3-030-16624-3
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
館藏地:
全部
電子資源
出版年:
卷號:
館藏
1 筆 • 頁數 1 •
1
條碼號
典藏地名稱
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
W9374510
電子資源
11.線上閱覽_V
電子書
EB RC271.C5 C36 2019
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
評論
新增評論
分享你的心得
Export
取書館
處理中
...
變更密碼
登入